Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Elena Almagro
Observed names:
E. Almagro,
E. Almagro Casado,
E. Almagro-Casado,
ELENA ALMAGRO CASADO,
Elena Almagro-Casado
Observed institutions:
University of British Columbia,
Hospital Universitario Puerta de Hierro Majadahonda,
Hospital Universitario Quirónsalud Madrid,
Hospital Universitario de León,
Vancouver Prostate Centre,
IDCQ Hospitales y Sanidad, S.L.U.,
Universidad Europea de Madrid
show all 7
ORCID:
0000-0002-2004-4911
Observed ORCID:
0000-0002-2004-4911
OpenAlex ID:
A5103012891
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
2020
·
Thomas Powles
, Michiel S van der Heijden
, et al.
·
The Lancet Oncology
·
518
PDF
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
2025
·
Maria De Santis
, Joan Palou Redorta
, et al.
·
The Lancet
·
104
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
2020
·
Pablo Guisado-Vasco
, Sofia Valderas-Ortega
, et al.
·
EClinicalMedicine
·
94
PDF
HSD3B1 (1245A>C) germline variant and clinical outcomes in metastatic castration-resistant prostate cancer patients treated with abiraterone and enzalutamide: results from two prospective studies
2020
·
D.J. Khalaf
, I.M. Aragón
, et al.
·
Annals of Oncology
·
48
Clinical Applications of Molecular Biomarkers in Prostate Cancer
2020
·
Felipe Couñago
, Fernando López-Campos
, et al.
·
Cancers
·
43
PDF
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study
2023
·
Nuria Romero-Laorden
, David Lorente
, et al.
·
European Urology Oncology
·
19
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma
2015
·
E. Almagro-Casado
, A. Sánchez
, et al.
·
Clinical & Translational Oncology
·
16
Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report
2013
·
A. López-González
, E. Almagro
, et al.
·
Respiratory Medicine Case Reports
·
16
PDF
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers
2023
·
Rebeca Lozano
, Elena Castro
, et al.
·
European Journal of Cancer
·
14
The role of anthracyclines in small cell lung cancer.
2013
·
Ana López-González
, Pilar Diz
, et al.
·
PubMed
·
13
Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer
2020
·
David Lorente
, Elena Castro
, et al.
·
European Urology
·
11
Prognostic factors of early breast cancer
2016
·
Elena Almagro
, Cynthia S. González
, et al.
·
Medicina Clínica (English Edition)
·
8
Factores pronósticos en el cáncer de mama en estadio inicial
2015
·
Elena Almagro
, Cynthia S. González
, et al.
·
Medicina Clínica
·
6
Clinical pretreatment risk factors and prediction of outcome using gallium 67 scintigraphy in patients with Hodgkin's lymphoma
2015
·
IGNACIO GARCÍA ESCOBAR
, ANA LÓPEZ
, et al.
·
Molecular and Clinical Oncology
·
3
PDF
Relevance of radium-223 in hospital clinical practice from a medical oncologist point of view
2019
·
R. Lozano
, E. Almagro
, et al.
·
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
·
2
Neuroendocrine differentiation in carcinoma of the prostate: An institutional review.
2014
·
David Perez
, Estefania Linares
, et al.
·
Journal of Clinical Oncology
·
2
Cabazitaxel versus enzalutamide/abiraterone in CARD eligible mCRPC patients with or without germline HRR defects.
2020
·
Nuria Romero-Laorden
, Rebeca Lozano
, et al.
·
Journal of Clinical Oncology
·
1
Enteritis inducida por quimioterapia: experiencia institucional y revisión bibliográfica
2019
·
E. Almagro Casado
, L. Gutierrez
, et al.
·
Revista Clínica Española
·
1
Importancia del radio-223 en la práctica hospitalaria. Visión del oncólogo médico
2019
·
R. Lozano
, E. Almagro
, et al.
·
Revista Española de Medicina Nuclear e Imagen Molecular
·
1
Hybrid scheme with carboplatin and etoposide intravenous (iv) and oral in patients with small cell lung cancer: Should we treat in a different way based on the age?
2012
·
Andrea Ruiz-Valdepeñas
, Magda Palka
, et al.
·
Journal of Clinical Oncology
·
1
Reactivación de un síndrome paraneoplásico anti-Hu en paciente con cáncer microcítico de pulmón tratado con inmunoterapia: desafío diagnóstico y terapéutico
2026
·
Amparo López-Bonelo
, Elena Almagro-Casado
, et al.
·
GECP Lung Cancer & Clinical Research Journal
PDF
628P Treatment in CARD eligible metastatic castration resistant prostate cancer (mCRPC) patients according to the status of germline HRR mutations: Cabazitaxel (CBZ) vs enzalutamide/abiraterone
2020
·
C. Llacer Perez
, N. Romero Laorden
, et al.
·
Annals of Oncology
Outcomes of metastatic castration resistant prostate cancer (mCRPC) patients with DNA repair germline mutations (gDDR) following first taxane-based treatment.
2018
·
Javier Puente
, Nuria Romero-Laorden
, et al.
·
Journal of Clinical Oncology
3T Multiparametric Magnetic Resonance Imaging-Guided High-Dose Salvage Radiotherapy in Prostate Cancer
2017
·
F. Counago
, E. del Cerro
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Does the Presence of Hepatitis Virus B & C Influence the Evolution of Diffuse Large B-Cell Lymphomas?
2014
·
J. Rubio-Martínez
, F. Franco
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
33
Citation count:
921
H-index:
11
I10-index:
11
Year
Topic
Type
